• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 2010 年季节性流行期间,纽约地区献血者中的西尼罗河病毒感染。

West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.

机构信息

New York Blood Center, New York 10065, USA.

出版信息

Transfusion. 2012 Dec;52(12):2664-70. doi: 10.1111/j.1537-2995.2012.03639.x. Epub 2012 Apr 9.

DOI:10.1111/j.1537-2995.2012.03639.x
PMID:22486471
Abstract

BACKGROUND

A uniform threshold strategy for converting from minipool (MP)-nucleic acid testing (NAT) to individual donation (ID)-NAT screening for acute West Nile virus (WNV) infection among blood donors is lacking. We report on WNV screening at the New York Blood Center during the 2010 seasonal WNV epidemic, the most severe epidemic in that state since the original outbreak in 1999.

STUDY DESIGN AND METHODS

Between July 1 and October 31, 2010, blood donations were screened by MP-NAT or ID-NAT and the presence of anti-WNV immunoglobulin (Ig)M and IgG was evaluated among NAT-positive donations.

RESULTS

Twenty presumed viremic donations were identified for a frequency of 0.0129% (1 in 7752 donations). Nine donations that could have been missed by MP-NAT were identified. Two of these donations were both IgM and IgG negative, one of which would have been missed if more than one positive donation was required for initiating ID-NAT. Retrospective ID-NAT revealed two positive donations. The majority of the NAT-positive donations in New York (16/19) were from donors who lived in counties that had the highest incidence of human WNV cases in the state.

CONCLUSION

Our data details the identification of WNV NAT-positive blood donations during a severe seasonal epidemic in the New York area. By initiating ID-NAT after one positive donation, using retrospective testing, and triggering ID-NAT regionally, we were able to prevent the release of presumably infectious donations. The detection of NAT-positive donations with retrospective testing, however, may indicate the need for changes in our trigger criteria.

摘要

背景

对于急性西尼罗河病毒(WNV)感染的献血者,从微池(MP)-核酸检测(NAT)转换为个体供者(ID)-NAT 筛查,缺乏统一的阈值策略。我们报告了 2010 年季节性 WNV 流行期间纽约血液中心的 WNV 筛查情况,这是自 1999 年最初爆发以来该州最严重的一次流行。

研究设计和方法

2010 年 7 月 1 日至 10 月 31 日,通过 MP-NAT 或 ID-NAT 筛查献血,评估 NAT 阳性献血中抗 WNV 免疫球蛋白(Ig)M 和 IgG 的存在。

结果

确定了 20 份疑似病毒血症供者,频率为 0.0129%(1 例/7752 例供者)。发现了 9 例可能被 MP-NAT 遗漏的供者。其中 2 例 IgM 和 IgG 均为阴性,如果需要多于 1 例阳性供者来启动 ID-NAT,其中 1 例可能会被遗漏。回顾性 ID-NAT 显示有 2 例阳性供者。纽约的大多数 NAT 阳性供者(16/19)来自该州人类 WNV 病例发病率最高的县的供者。

结论

我们的数据详细描述了在纽约地区严重季节性流行期间发现的 WNV NAT 阳性献血。通过在 1 例阳性供者后启动 ID-NAT、使用回顾性检测和区域性触发 ID-NAT,我们能够防止传染性供者的血液放行。然而,通过回顾性检测发现 NAT 阳性供者,可能表明我们的触发标准需要改变。

相似文献

1
West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.在 2010 年季节性流行期间,纽约地区献血者中的西尼罗河病毒感染。
Transfusion. 2012 Dec;52(12):2664-70. doi: 10.1111/j.1537-2995.2012.03639.x. Epub 2012 Apr 9.
2
A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.一种用于评估和比较从西尼罗河病毒小型混合检测转换为个体捐赠者检测的触发策略的建模框架。
Transfusion. 2009 Jun;49(6):1151-9. doi: 10.1111/j.1537-2995.2009.02112.x. Epub 2009 Feb 27.
3
West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.2007年西尼罗河病毒检测经验:触发个体献血核酸检测的不同标准评估
Transfusion. 2009 Jun;49(6):1160-70. doi: 10.1111/j.1537-2995.2009.02127.x. Epub 2009 Mar 20.
4
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.通过核酸扩增检测对血液供应进行西尼罗河病毒RNA筛查。
N Engl J Med. 2005 Aug 4;353(5):460-7. doi: 10.1056/NEJMoa044029.
5
West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.2006 年和 2007 年的西尼罗河病毒:加拿大血液服务中心的经验。
Transfusion. 2010 May;50(5):1118-25. doi: 10.1111/j.1537-2995.2009.02550.x. Epub 2009 Dec 29.
6
West Nile virus in Canadian blood donors.加拿大献血者中的西尼罗河病毒。
Transfusion. 2005 Apr;45(4):487-91. doi: 10.1111/j.0041-1132.2005.04384.x.
7
Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.从西尼罗河病毒核酸技术的混合样本检测转向单份献血核酸检测的触发因素:对2003年数据的分析为2004年决策提供依据
Transfusion. 2004 Nov;44(11):1547-54. doi: 10.1111/j.0041-1132.2004.04227.x.
8
Reacting to an emerging safety threat: West Nile virus in North America.应对新出现的安全威胁:北美洲的西尼罗河病毒。
Dev Biol (Basel). 2007;127:43-58.
9
The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.2003年美国西尼罗河病毒疫情:美国血液中心的经历。
Transfusion. 2005 Apr;45(4):469-79. doi: 10.1111/j.0041-1132.2005.04315.x.
10
West Nile virus among blood donors in the United States, 2003 and 2004.2003年和2004年美国献血者中的西尼罗河病毒
N Engl J Med. 2005 Aug 4;353(5):451-9. doi: 10.1056/NEJMoa044333.

引用本文的文献

1
Neuroinvasive West Nile Virus Infection in Immunosuppressed and Immunocompetent Adults.免疫抑制和免疫功能正常成人的神经侵袭性西尼罗河病毒感染。
JAMA Netw Open. 2024 Mar 4;7(3):e244294. doi: 10.1001/jamanetworkopen.2024.4294.
2
Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012.2010 - 2012年美国献血中西尼罗河病毒发病率与西尼罗河神经侵袭性疾病发病率的相关性
Emerg Infect Dis. 2017 Feb;23(2):212-219. doi: 10.3201/eid2302.161058. Epub 2017 Feb 15.
3
Improving platelet transfusion safety: biomedical and technical considerations.
提高血小板输注安全性:生物医学与技术考量
Blood Transfus. 2016 Mar;14(2):109-22. doi: 10.2450/2015.0042-15. Epub 2015 Nov 16.
4
Pathogen inactivation technologies for cellular blood components: an update.细胞血液成分的病原体灭活技术:更新。
Transfus Med Hemother. 2014 Jul;41(4):309-25. doi: 10.1159/000365646. Epub 2014 Jul 21.
5
West Nile virus state of the art report of MALWEST Project.西尼罗河病毒MALWEST项目的最新报告。
Int J Environ Res Public Health. 2013 Dec 2;10(12):6534-610. doi: 10.3390/ijerph10126534.